Delivery Order SPE2DB20D2104-SPE2DB22FS92D

Award Date 6/3/22
Potential Completion Date 6/6/22
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,021.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oseltamivir 6 mg/ml suspension (60 ml) and has a completion date of November 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that serves as a critical supplier of pharmaceutical products and medical supplies to...
This federal contract award, valued at $2,604.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Oseltamivir 6 mg/ml suspension, a critical antiviral medication, for a period ending on December 23, 2024. The contract has a firm fixed-price pricing structure and was not designated as a set-aside. AmerisourceBergen holds a substantial Indefinite...
This federal contract award is for the delivery of Oseltamivir 6 mg/ml suspension in 60 ml bottles to the Defense Logistics Agency (DLA). The contract, valued at $2,267.72, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 3, 2022, with a completion date of November 4, 2022. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This federal contract award is for the delivery of Oseltamivir 6 mg/ml suspension in 60 ml bottles to the Defense Logistics Agency (DLA). The contract, valued at $2,980.40, was awarded to AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The contract has a period of performance through February 22, 2024. The contract is a delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $2,162.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Oseltamivir Phosphate 30 mg capsules, with a completion date of April 4, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov). The company...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order (SPE2DB23FQVP9) under the Defense Logistics Agency's (DLA) Indefinite Delivery Contract (IDC) SPE2DB20D3101, valued at $2,444.45 for the purchase of Oseltamivir 6 mg/ml suspension (60 ml). The contract was awarded on November 25, 2022, with an ultimate completion date of November 28, 2022. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider, registered in the System for Award...
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules, awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract award, valued at $1,214.38, was issued by the Defense Logistics Agency (DLA) as a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,059.25 firm fixed-price contract is for the delivery of 60 ml bottles of the antiviral medication oseltamivir 6 mg/ml suspension with a completion date of December 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Oseltamivir 6 mg/mL suspension in 60 mL bottles. The firm-fixed-price contract has a ceiling value of $1,584.91 and an ultimate completion date of September 13, 2021. This contract is not designated with a set-aside requirement. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The $5,902.51 firm-fixed-price delivery order is for the supply of Oseltamivir Phosphate 45 mg capsules, a medication used to treat influenza. The contract has an ultimate completion date of December 27, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FS92D
    Delivery Order

This federal contract award, valued at $1,168.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Oseltamivir 6 mg/ml suspension 60ml, a critical antiviral medication. The contract has a completion date of June 6, 2022 and is structured as a firm fixed-price delivery order.

Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Both companies are for-profit organizations registered in the System for Award Management (SAM.gov). Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 2/27/25, 12:31 PM